---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-023321"
form_type: "8-K"
ticker: "AXTI"
cik: "0001051627"
company_name: "AXT INC"
filed_at: "2025-07-23T23:59:59+00:00"
generated_at: "2026-05-18T03:05:51.676687+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# AXT non-compliant with Nasdaq audit committee rules after director death; cure period through mid-2026

## Summary
- Passing of director Christine Russell left Audit Committee with only two independent directors, violating Nasdaq Rule 5605(c)(2)(A).
- Nasdaq granted cure period: compliance required by earlier of next annual meeting or July 11, 2026.
- If 2025 annual meeting held before Jan 7, 2026, compliance deadline is Jan 7, 2026 instead.
- Company intends to regain compliance by appointing a new independent director meeting Nasdaq requirements.

## SEC filing metadata
- accession: 0001437749-25-023321
- form_type: 8-K
- ticker: AXTI
- cik: 0001051627
- company_name: AXT INC
- filed_at: 2025-07-23T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1051627/000143774925023321/0001437749-25-023321-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1051627/000143774925023321/axti20250722_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-023321
- JSON: https://secwatch.observer/filing/0001437749-25-023321.json
- Plain text: https://secwatch.observer/filing/0001437749-25-023321.txt

## Source-grounded claims
- claim_id: af973a2e9c5f0605ae4b95b86cdba344da064856
  claim: AXT INC received a nasdaq deficiency notice notice regarding audit committee (rules 5605(c)(2)(A), 5605(c)(4)).
  evidence_excerpt: January 18, 2025, Nasdaq notified the Company that due to the passing of Ms. Russell, the Company no longer complies with the audit committee requirement under Nasdaq Lising Rule 5605(c)(2)(A). Nasdaq further notified the Company that, consistent with Nasdaq Listing Rule 5605(c)(4), Nasdaq will provide the Company a cure period in order to regain compliance (i) until the earlier of the Company’s next annual meeting of shareholders or July 11, 2026; or, (ii) if the next annual meeting of shareholders is held before January 7, 2026, then the Company must provide evidence of compliance no later t
  evidence_url: https://www.sec.gov/Archives/edgar/data/1051627/000143774925023321/0001437749-25-023321-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.